Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05887050 · ClinicalTrials.gov registry record · NA

Effects of a Dietary Supplement Containing Salacia Extract, Citrus Bioflavonoids, and Trivalent Chromium on Markers of Glucose Control

A NA study, sponsored by The Center for Applied Health Sciences.

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT05887050 is a NA study that has completed, run by The Center for Applied Health Sciences. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05887050, a NA study, has completed, sponsored by The Center for Applied Health Sciences.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

This study was a double-blind, randomized, placebo-controlled, clinical trial with two parallel groups. Participants reported to a single investigational center in Ohio (i.e., The Center for Applied Health Sciences) during the 12 week trial.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Active

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2020-12-03
Est. Completion 2021-07-20
Phase NA

What the Registry Record Tells You About NCT05887050

The ClinicalTrials.gov registry entry for NCT05887050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Center for Applied Health Sciences, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT05887050 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05887050 about?

NCT05887050 is a clinical study titled "Effects of a Dietary Supplement Containing Salacia Extract, Citrus Bioflavonoids, and Trivalent Chromium on Markers of Glucose Control". This study was a double-blind, randomized, placebo-controlled, clinical trial with two parallel groups. Participants reported to a single investigational center in Ohio (i.e., The Center for Applied Health Sciences) during the 12 week trial.

What is the current status of trial NCT05887050?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-12-03. Estimated completion is 2021-07-20.

What interventions are being tested in trial NCT05887050?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Active (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05887050?

This trial is sponsored by The Center for Applied Health Sciences, which has 12 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.